Startup profile · funding coverage
Pomelo Care funding, valuation and investors
Virtual maternal and newborn care platform for health plans and employers.
Keep track of Pomelo Care
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C
$92M · 2026
Latest known valuation
$1.7B
Series C · 2026
Total disclosed equity funding
$125M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, USA
Investors in latest funding
Other: Andreessen Horowitz
Overview
Pomelo Care delivers virtual-first maternal and newborn care: 24/7 clinical support, proactive outreach for high-risk pregnancies, and coordination with in-person OB care. Founded by former healthcare operators, Pomelo contracts with health plans and employers. a16z Bio+Health led $33M combined seed and Series A (2023) with First Round; Stripes led $92M Series C (2026) at $1.7B with a16z re-upping.
Why Pomelo Care is interesting
a16z Bio+Health led $33M seed/Series A (2023) then re-upped at $92M Series C (2026) at $1.7B — maternity vertical care delivery, not just navigation.
Product & use cases
Pomelo assigns care teams to pregnant members for chat/phone access, remote monitoring, and escalation to OB hospitals — aiming to reduce NICU and complication costs for payers.
- High-risk pregnancy monitoring for Medicaid and commercial plans
- Employer benefit for maternal health support
- Postpartum and newborn guidance in first weeks
- Reducing avoidable ER visits during pregnancy
Key facts
- Series C (2026): $92M at $1.7B led by Stripes; a16z re-upped
- Seed/Series A (2023): $33M led by a16z Bio+Health
- Virtual maternal and newborn care for payers
Funding history (newest first)
Series C
2026 $92M Valuation: $1.7BSource: https://www.prnewswire.com/news-releases/pomelo-care-series-c/
Series A
2023 $33MSource: https://www.businesswire.com/news/pomelo-care-funding-2023
Investors in our directory
Funds linked from Pomelo Care's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Full-stack virtual maternity clinic vs point solutions; rapid Series C valuation reflects payer contract momentum.
Maternal health VC heated post-Roe and Medicaid expansion. Pomelo competes on clinical outcomes data and plan ROI vs Maven's broader women's health brand.
-
Maven Clinic direct
Virtual women's and family health platform.
-
Wildflower Health adjacent
Maternity navigation and engagement.
-
Traditional OB practices incumbent
In-person care; Pomelo wraps around them.
Notable stories
- Pomelo reached unicorn valuation in ~5 years by selling outcomes-based contracts to plans focused on maternal morbidity reduction.
Industries
FAQs about Pomelo Care
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.